Evaluation and Management of Isolated Monocytosis

Definition and Initial Confirmation

• Monocytosis is defined as an absolute monocyte count > 1 × 10⁹ /L ( > 1000 /µL) 1.
• Persistent elevation should be confirmed by repeating a complete blood count with differential after 2–4 weeks, because transient monocytosis may occur with acute infections 1.
• The peripheral blood smear must be examined for dysgranulopoiesis, promonocytes, blasts, and neutrophil precursors to identify possible malignant features 1.

Critical Exclusion of Chronic Myelomonocytic Leukemia (CMML)

• If monocytosis persists for ≥ 3 months, CMML must be excluded, especially when any of the following are present: dysplasia on smear, splenomegaly, or constitutional symptoms such as fatigue, weight loss, or night sweats 1.
• The absence of an elevated total white‑blood‑cell count does not rule out CMML; a “dysplastic” variant (MD‑CMML) may present with a total WBC < 13 × 10⁹ /L 1.

Required Bone‑Marrow Work‑up When CMML Is Suspected

• Perform bone‑marrow aspiration and biopsy, including:
  
  • Conventional cytogenetic analysis to exclude t(9;22) and t(5;12) translocations 1.
  • BCR‑ABL fusion‑gene molecular assay to rule out chronic myeloid leukemia 1.
  • PDGFRA and PDGFRB rearrangement testing if eosinophilia is present 1.
  • Morphologic assessment for dysplasia in myeloid lineages 1.
  • Determination of blast percentage; a value < 20 % is required for a CMML diagnosis 1.
• Store the bone‑marrow specimen for possible future molecular analyses 1.

Evaluation for Secondary (Non‑malignant) Causes

• Infectious etiologies – screen for chronic infections such as tuberculosis, subacute bacterial endocarditis, and fungal infections 1. Recommended investigations include chest radiography, blood cultures if febrile, tuberculosis screening, and HIV testing 1.
• Malignancy‑related monocytosis – solid tumors, particularly gastrointestinal and lung cancers, can present with isolated monocytosis 1. Age‑appropriate cancer screening and, when constitutional symptoms are present, CT of the chest/abdomen/pelvis are advised 1.

General Practical Recommendations

• Do not rely on the monocyte percentage alone; the absolute monocyte count is the decisive laboratory parameter 1.
• When the clinical picture includes monocytosis ≥ 3 months, any cytopenias, dysplastic changes on smear, or constitutional symptoms, promptly proceed to bone‑marrow evaluation 1.

All statements are based on evidence and expert consensus from Haematologica (2013) 1.